Magnetic resonance imaging in patients with pacemakers and implantable cardioverter-defibrillators: A systematic review;Imagerie par résonance magnétique chez les patients porteurs de stimulateurs cardiaques et de défibrillateurs automatiques implantables: revue de la littérature

Annales de Cardiologie et d'Angeiologie

Volumn 59, Issue 4, 2010, Pages 221-228

  Martins, R P ^a,b,c   Baruteau, A E ^a,b,c   Treguer, F ^a,d   Cesari O ^a   Carsin Nicol, B ^a   Langella, B ^a   Leclercq, C ^a,b,c   Daubert, J C ^a,b,c   Mabo, P ^a,b,c  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c INSERM   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Electromagnetic interference; Implantable cardioverter defibrillator; Magnetic resonance imaging; Pacemaker; Safety

Indexed keywords

ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTROMAGNETIC FIELD; HUMAN; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY; SAFETY; SHORT SURVEY; SYSTEMATIC REVIEW;

EID: 77956615114     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2009.04.003     Document Type: Short Survey

References (44)

1. Shellock F.G., Crues J.V. MR procedures: biologic effects, safety, and patient care. Radiology 2004, 232:635-652.
2. Edwards M.B., Taylor K.M., Shellock F.G. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5T. J Magn Reson Imaging 2000, 12:363-369.
3. Levine G.N., Gomes A.S., Arai A.E., Bluemke D.A., Flamm S.D., Kanal E., et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on diagnostic and interventional cardiac catheterization, Council on clinical cardiology, and the Council on cardiovascular radiology and intervention: endorsed by the American College of cardiology foundation, the North American Society for cardiac imaging, and the Society for cardiovascular magnetic resonance. Circulation 2007, 116:2878-2891.
4. Pavlicek W., Geisinger M., Castle L., Borkowski G.P., Meaney T.F., Bream B.L., et al. The effects of nuclear magnetic resonance on patients with cardiac pacemakers. Radiology 1983, 147:149-153.
5. Avery J.K. Loss Prevention case of the month. Not my responsibility!. J Tenn Med Assoc 1988, 81:523.
6. Irnich W., Irnich B., Bartsch C., Stertmann W.A., Gufler H., Weiler G. Do we need pacemakers resistant to magnetic resonance imaging?. Europace 2005, 7:353-365.
7. Kalin R., Stanton M.S. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005, 28:326-328.
8. Medtronic data on file.
9. Luechinger R., Duru F., Scheidegger M.B., Boesiger P., Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001, 24:199-205.
10. Shellock F.G., Fischer L., Fieno D.S. Cardiac pacemakers and implantable cardioverter defibrillators: in vitro magnetic resonance imaging evaluation at 1.5-tesla. J Cardiovasc Magn Reson 2007, 9:21-31.
11. Roguin A., Zviman M.M., Meininger G.R., Rodrigues E.R., Dickfeld T.M., Bluemke D.A., et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5T. Circulation 2004, 110:475-482.
12. Nazarian S., Roguin A., Zviman M.M., Lardo A.C., Dickfeld T.L., Calkins H., et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5tesla. Circulation 2006, 114:1277-1284.
13. Sommer T., Naehle C.P., Yang A., Zeijlemaker V., Hackenbroch M., Schmiedel A., et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006, 114:1285-1292.
14. Sommer T., Vahlhaus C., Lauck G., von Smekal A., Reinke M., Hofer U., et al. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5T. Radiology 2000, 215:869-879.
15. Martin E.T., Coman J.A., Shellock F.G., Pulling C.C., Fair R., Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004, 43:1315-1324.
16. Gimbel J.R., Kanal E., Schwartz K.M., Wilkoff B.L. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICD). Pacing Clin Electrophysiol 2005, 28:270-273.
17. Shellock F.G., Fieno D.S., Thomson L.J., Talavage T.M., Berman D.S. Cardiac pacemaker: in vitro assessment at 1.5T. Am Heart J 2006, 151:436-443.
18. Shellock F.G., Tkach J.A., Ruggieri P.M., Masaryk T.J. Cardiac pacemakers, ICD, and loop recorder: evaluation of translational attraction using conventional " long-bore" and " short-bore" 1.5- and 3. 0-Tesla MR systems. J Cardiovasc Magn Reson 2003, 5:387-397.
19. Price R.R. The AAPM/RSNA physics tutorial for residents. MR imaging safety considerations. Radiological Society of North America. Radiographics 1999, 19:1641-1651.
20. Luechinger R., Duru F., Zeijlemaker V.A., Scheidegger M.B., Boesiger P., Candinas R. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields?. Pacing Clin Electrophysiol 2002, 25:1419-1423.
21. Fries R., Steuer M., Schafers H.J., Bohm M. The R-on-T phenomenon in patients with implantable cardioverter-defibrillators. Am J Cardiol 2003, 91:752-755.
22. Frank R., Hidden-Lucet F., Himbert C., Petitot J.C., Fontaine G. Cardiac Pacemakers, implantable defibrillators and IRM. Arch Mal Coeur Vaiss 2003, 96(Spec No 3):46-49.
23. Vahlhaus C., Sommer T., Lewalter T., Schimpf R., Schumacher B., Jung W., et al. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5Tesla?. Pacing Clin Electrophysiol 2001, 24:489-495.
24. Gaffey C.T., Tenforde T.S. Alterations in the rat electrocardiogram induced by stationary magnetic fields. Bioelectromagnetics 1981, 2:357-370.
25. Tenforde T.S., Gaffey C.T., Moyer B.R., Budinger T.F. Cardiovascular alterations in Macaca monkeys exposed to stationary magnetic fields: experimental observations and theoretical analysis. Bioelectromagnetics 1983, 4:1-9.
26. Duru F., Luechinger R., Scheidegger M.B., Luscher T.F., Boesiger P., Candinas R. Pacing in magnetic resonance imaging environment: clinical and technical considerations on compatibility. Eur Heart J 2001, 22:113-124.
27. Lauck G., von Smekal A., Wolke S., Seelos K.C., Jung W., Manz M., et al. Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol 1995, 18:1549-1555.
28. Achenbach S., Moshage W., Diem B., Bieberle T., Schibgilla V., Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997, 134:467-473.
29. Heatlie G., Pennell D.J. Cardiovascular magnetic resonance at 0.5T in five patients with permanent pacemakers. J Cardiovasc Magn Reson 2007, 9:15-19.
30. Anfinsen O.G., Berntsen R.F., Aass H., Kongsgaard E., Amlie J.P. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002, 25:1400-1402.
31. Naehle C.P., Sommer T., Meyer C., Strach K., Kreuz J., Litt H., et al. Strategy for safe performance of magnetic resonance imaging on a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2006, 29:113-116.
32. Luechinger R., Zeijlemaker V.A., Pedersen E.M., Mortensen P., Falk E., Duru F., et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005, 26:376-383. discussion 25-7.
33. Fontaine J.M., Mohamed F.B., Gottlieb C., Callans D.J., Marchlinski F.E. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998, 21:1336-1339.
34. Hayes D.L., Holmes D.R., Gray J.E. Effect of 1.5tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol 1987, 10:782-786.
35. Rozner M.A., Burton A.W., Kumar A. Pacemaker complication during magnetic resonance imaging. J Am Coll Cardiol 2005, 45:161-162. author reply 2.
36. Fiek M., Remp T., Reithmann C., Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. Pacing Clin Electrophysiol 2004, 27:1002-1004.
37. Schueler B.A., Parrish T.B., Lin J.C., Hammer B.E., Pangrle B.J., Ritenour E.R., et al. MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging 1999, 9:596-603.
38. Gimbel J.R., Johnson D., Levine P.A., Wilkoff B.L. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996, 19:913-919.
39. Gimbel J.R., Bailey S.M., Tchou P.J., Ruggieri P.M., Wilkoff B.L. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005, 28:1041-1046.
40. Roguin A., Schwitter J., Vahlhaus C., Lombardi M., Brugada J., Vardas P., et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008, 10:336-346.
41. Nazarian S., Halperin H.R. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm 2009, 6:138-143.
42. Hartnell G.G., Spence L., Hughes L.A., Cohen M.C., Saouaf R., Buff B. Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR Am J Roentgenol 1997, 168:1157-1159.
43. Del Ojo J.L., Moya F., Villalba J., Sanz O., Pavon R., Garcia D., et al. Is magnetic resonance imaging safe in cardiac pacemaker recipients?. Pacing Clin Electrophysiol 2005, 28:274-278.
44. Faris O.P., Shein M.J. Government viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI. Pacing Clin Electrophysiol 2005, 28:268-269.